Status:
WITHDRAWN
Telomere and Telomerase
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18+ years
Brief Summary
Researchers hope to determine if the DNA is shortened in your body and determine if there is an increase in the protein that shortens DNA called telomerase.
Detailed Description
A telomere is a region of repetitive DNA at the end of chromosomes, which protects the end of the chromosome from destruction. Telomeres can be viewed as the tips on the ends of shoelaces that keep th...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of advanced Myelodysplastic Syndrome (MDS) or acute myeloid leukemia
- must be 18 years of age
- must be able to give written informed consent
Exclusion
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01176422
Start Date
September 1 2010
End Date
February 1 2011
Last Update
January 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center, Westwood Campus
Westwood, Kansas, United States, 66205